Home › Funds › Millennium Management › CHRS

Millennium Management position in CHRS

COHERUS ONCOLOGY INC · Health Care

Latest position (Q2 2026)20.75K sh
Reported value held$29.05K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q3 2021 484.02K $7.78M New
Q4 2021 330.44K $5.27M Reduce
Q1 2022 202.06K $2.61M Reduce
Q2 2022 389.31K $2.82M Add
Q3 2022 517.15K $4.97M Add
Q4 2022 542.62K $4.30K Add
Q1 2023 218.47K $1.49K Reduce
Q2 2023 852.47K $3.64M Add
Q3 2023 216.68K $810.38K Reduce
Q4 2023 2.84M $9.46M Add
Q1 2024 1.26M $3.01M Reduce
Q2 2024 616.03K $1.07M Reduce
Q3 2024 797.51K $829.41K Add
Q4 2024 1.05M $1.45M Add
Q1 2025 2.90M $2.34M Add
Q2 2025 1.38M $1.01M Reduce
Q4 2025 660.45K $937.84K New
Q1 2026 311.99K $527.26K Reduce
Q2 2026 20.75K $29.05K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding CHRS

All CHRS fund holders →